Symptomtext
Expired pentacel was administered with no reported adverse event; Initial information received on 20-May-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a patient of an unknown age and gender and it was reported expired pentacel was administered with no reported adverse event , while receiving vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 20-May-2022, the patient received an unknown dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE, ( lot : UJ433AA; expiry date: 17-May-2022) in unknown administration site for prophylactic vaccination. It was reported that expired pentacel was administered on 20-May-2022 and it expired 3 days prior (expired product administered) (unknown latency) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE. Action taken : not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.